Crown Bioscience (China)

Uniform nomenclature for the mitochondrial contact site and cristae organizing system

Nikolaus Pfanner, Martin van der Laan, Paolo Amati et al. · The Journal of Cell Biology · 2014 · 252 citations · Full text

Biology, Mitochondrial Inner Membrane, Uniform Nomenclature +15

Identification of apilimod as a first-in-class PIKfyve kinase inhibitor for treatment of B-cell non-Hodgkin lymphoma

Sophia Gayle, Sean F. Landrette, Neil Beeharry et al. · Blood · 2017 · 198 citations · Full text

LY2801653 is an orally bioavailable multi-kinase inhibitor with potent activity against MET, MST1R, and other oncoproteins, and displays anti-tumor activities in mouse xenograft models

S. Betty Yan, Victoria L. Peek, Rose T. Ajamie et al. · Investigational New Drugs · 2012 · 159 citations · Full text

Biomarker Analyses from a Placebo-Controlled Phase II Study Evaluating Erlotinib ± Onartuzumab in Advanced Non–Small Cell Lung Cancer: MET Expression Levels Are Predictive of Patient Benefit

Hartmut Koeppen, Wei Yu, Jiping Zha et al. · Clinical Cancer Research · 2014 · 131 citations · Full text

Label-free mass spectrometry-based protein quantification technologies in proteomic analysis

Mu Wang, Jingjing You, Kerry G. Bemis et al. · Briefings in Functional Genomics and Proteomics · 2008 · 129 citations · Full text

Protein Analysis, Proteomic Technology, Bioanalysis +17